Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection
- PMID: 29520176
- PMCID: PMC5840047
- DOI: 10.3348/kjr.2018.19.2.193
Prostate Imaging-Reporting and Data System Version 2: Beyond Prostate Cancer Detection
Abstract
The main purpose of Prostate Imaging-Reporting and Data System Version 2 (PI-RADSv2) is to effectively detect clinically significant prostate cancers (csPCa) using multiparametric magnetic resonance imaging. Since the first introduction of PI-RADSv2, researchers have validated its diagnostic performance in identifying csPCa, and these promising data have influenced biopsy and treatment schemes. However, in this article, we focused on the potential of PI-RADSv2 in relation to various aspects of PCa such as Gleason score, tumor volume, extraprostatic extension, lymph node metastasis, and postoperative biochemical recurrence, beyond prostate cancer detection.
Keywords: Magnetic resonance imaging; PI-RADS; Prognosis; Prostate cancer; Recurrence.
Figures






Similar articles
-
Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.J Urol. 2016 Sep;196(3):690-6. doi: 10.1016/j.juro.2016.04.057. Epub 2016 Apr 18. J Urol. 2016. PMID: 27101772
-
PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer.AJR Am J Roentgenol. 2017 Jul;209(1):W1-W9. doi: 10.2214/AJR.16.16981. Epub 2017 Apr 18. AJR Am J Roentgenol. 2017. PMID: 28418690
-
Impact of the Prostate Imaging Reporting and Data System, Version 2, on MRI Diagnosis for Extracapsular Extension of Prostate Cancer.AJR Am J Roentgenol. 2017 Aug;209(2):W76-W84. doi: 10.2214/AJR.16.17163. Epub 2017 Jun 1. AJR Am J Roentgenol. 2017. PMID: 28570124
-
A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores.AJR Am J Roentgenol. 2019 Apr;212(4):847-854. doi: 10.2214/AJR.18.20571. Epub 2019 Feb 26. AJR Am J Roentgenol. 2019. PMID: 30807218
-
Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis.Eur Urol. 2015 Jun;67(6):1112-1121. doi: 10.1016/j.eururo.2014.10.033. Epub 2014 Nov 6. Eur Urol. 2015. PMID: 25466942 Review.
Cited by
-
Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.Eur Radiol. 2020 Aug;30(8):4251-4261. doi: 10.1007/s00330-020-06725-9. Epub 2020 Mar 24. Eur Radiol. 2020. PMID: 32211965
-
Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study.Front Oncol. 2023 Nov 8;13:1241711. doi: 10.3389/fonc.2023.1241711. eCollection 2023. Front Oncol. 2023. PMID: 38023170 Free PMC article.
-
Risk Factors for Pathologically Confirmed Lymph Nodes Metastasis in Patients With Clinical T2N0M0 Stage Prostate Cancer.Front Oncol. 2020 Aug 14;10:1547. doi: 10.3389/fonc.2020.01547. eCollection 2020. Front Oncol. 2020. PMID: 32923401 Free PMC article.
-
Prostate Imaging Reporting and Data System in prostate cancer staging and planning for radical prostatectomy.Wideochir Inne Tech Maloinwazyjne. 2019 Apr;14(2):262-270. doi: 10.5114/wiitm.2019.83869. Epub 2019 Mar 26. Wideochir Inne Tech Maloinwazyjne. 2019. PMID: 31118993 Free PMC article.
-
MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study.Eur Radiol. 2021 Oct;31(10):7575-7583. doi: 10.1007/s00330-021-07856-3. Epub 2021 Apr 1. Eur Radiol. 2021. PMID: 33792737 Free PMC article.
References
-
- Park SY, Jung DC, Oh YT, Cho NH, Choi YD, Rha KH, et al. Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology. 2016;280:108–116. - PubMed
-
- Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Diagnostic performance of prostate imaging reporting and data system version 2 for detection of prostate cancer: a systematic review and diagnostic meta-analysis. Eur Urol. 2017;72:177–188. - PubMed
-
- Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y. A meta-analysis of use of prostate imaging reporting and data system version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol. 2017;27:5204–5214. - PubMed
-
- van As NJ, Norman AR, Thomas K, Khoo VS, Thompson A, Huddart RA, et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance. Eur Urol. 2008;54:1297–1305. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous